[1] 中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等.  甲状腺功能减退症基层诊疗指南(2019年)[J]. 中华全科医师杂志, 2019, 18(11): 1022-1028.   doi: 10.3760/cma.j.issn.1671-7368.2019.11.004
Chinese Medical Association, Chinese Medical Journals Publishing House, Chinese Society of General Practice, et al.  Guideline for primary care of hypothyroidism (2019)[J]. Chin J Gen Pract, 2019, 18(11): 1022-1028.   doi: 10.3760/cma.j.issn.1671-7368.2019.11.004
[2] Yang HX, Zhang M, Long SY, et al.  Cholesterol in LDL receptor recycling and degradation[J]. Clin Chim Acta, 2020, 500: 81-86.   doi: 10.1016/j.cca.2019.09.022
[3] Yildirim AM, Koca AO, Beyan E, et al.  Association of serum proprotein convertase Subtilisin/Kexin type 9 (PCSK9) level with thyroid function disorders[J]. Eur Rev Med Pharmacol Sci, 2021, 25(17): 5511-5517.   doi: 10.26355/eurrev_202109_26662
[4] Fazaeli M, Khoshdel A, Shafiepour M, et al.  The influence of subclinical hypothyroidism on serum lipid profile, PCSK9 levels and CD36 expression on monocytes[J]. Diabetes Metab Syndr, 2019, 13(1): 312-316.   doi: 10.1016/j.dsx.2018.08.021
[5] Delitala AP, Fanciulli G, Maioli M, et al.  Subclinical hypothyroidism, lipid metabolism and cardiovascular disease[J]. Eur J Intern Med, 2017, 38: 17-24.   doi: 10.1016/j.ejim.2016.12.015
[6]

Sun C, Liu W, Lu ZQ, et al. Hepatic miR-378 modulates serum cholesterol levels by regulating hepatic bile acid synthesis[J/OL]. Theranostics, 2021, 11(9): 4363−4380[2022-04-01]. https://www.thno.org/v11p4363.htm. DOI: 10.7150/thno.53624.
[7] Prieur X, Huby T, Coste H, et al.  Thyroid hormone regulates the hypotriglyceridemic gene APOA5[J]. J Biol Chem, 2005, 280(30): 27533-27543.   doi: 10.1074/jbc.M503139200
[8] Yang LY, Yin RL, Wang ZW, et al.  Circulating Angptl3 and Angptl8 are increased in patients with hypothyroidism[J]. Biomed Res Int, 2019, 2019: 3814687-.   doi: 10.1155/2019/3814687
[9] Jin NJ, Matter WF, Michael LF, et al.  The angiopoietin-like protein 3 and 8 complex interacts with lipoprotein lipase and induces LPL cleavage[J]. ACS Chem Biol, 2021, 16(3): 457-462.   doi: 10.1021/acschembio.0c00954
[10] Tian LM, Song YF, Xing MZ, et al.  A novel role for thyroid-stimulating hormone: up-regulation of hepatic 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase expression through the cyclic adenosine monophosphate/protein kinase A/cyclic adenosine monophosphate-responsive element binding protein pathway[J]. Hepatology, 2010, 52(4): 1401-1409.   doi: 10.1002/hep.23800
[11] Song YF, Xu C, Shao SS, et al.  Thyroid-stimulating hormone regulates hepatic bile acid homeostasis via SREBP-2/HNF-4α/CYP7A1 axis[J]. J Hepatol, 2015, 62(5): 1171-1179.   doi: 10.1016/j.jhep.2014.12.006
[12] Gong YY, Ma YZ, Ye ZQ, et al.  Thyroid stimulating hormone exhibits the impact on LDLR/LDL-c via up-regulating hepatic PCSK9 expression[J]. Metabolism, 2017, 76: 32-41.   doi: 10.1016/j.metabol.2017.07.006
[13] Zhou LY, Wu KP, Zhang LY, et al.  Liver-specific deletion of TSHR inhibits hepatic lipid accumulation in mice[J]. Biochem Biophys Res Commun, 2018, 497(1): 39-45.   doi: 10.1016/j.bbrc.2018.01.187
[14] Beukhof CM, Massolt ET, Visser TJ, et al.  Effects of thyrotropin on peripheral thyroid hormone metabolism and serum lipids[J]. Thyroid, 2018, 28(2): 168-174.   doi: 10.1089/thy.2017.0330
[15] Wang JJ, Zhuang ZH, Shao CL, et al.  Assessment of causal association between thyroid function and lipid metabolism: a Mendelian randomization study[J]. Chin Med J (Engl), 2021, 134(9): 1064-1069.   doi: 10.1097/CM9.0000000000001505
[16] Su X, Peng H, Chen X, et al.  Hyperlipidemia and hypothyroidism[J]. Clin Chim Acta, 2022, 527: 61-70.   doi: 10.1016/j.cca.2022.01.006
[17]

Saif A, Mousa S, Assem M, et al. Endothelial dysfunction and the risk of atherosclerosis in overt and subclinical hypothyroidism[J/OL]. Endocr Connect, 2018, 7(10): 1075−1080[2022-04-01]. https://ec.bioscientifica.com/view/journals/ec/7/10/EC-18-0194.xml. DOI: 10.1530/EC-18-0194.
[18] Li HY, Xu Q, Liu J, et al.  Detection of blood lipids, homocysteine and endothelin in patients with hypothyroidism and subclinical hypothyroidism and its clinical significance[J]. Am J Clin Exp Med, 2019, 7(1): 31-34.   doi: 10.11648/j.ajcem.20190701.14
[19] van der Boom T, Jia CZ, Lefrandt JD, et al.  HDL cholesterol efflux capacity is impaired in severe short-term hypothyroidism despite increased HDL cholesterol[J]. J Clin Endocrinol Metab, 2020, 105(9): e3355-e3362.   doi: 10.1210/clinem/dgaa411
[20] Jung KY, Ahn HY, Han SK, et al.  Association between thyroid function and lipid profiles, apolipoproteins, and high-density lipoprotein function[J]. J Clin Lipidol, 2017, 11(6): 1347-1353.   doi: 10.1016/j.jacl.2017.08.015
[21] Biondi B, Cappola AR, Cooper DS.  Subclinical hypothyroidism: a review[J]. JAMA, 2019, 322(2): 153-160.   doi: 10.1001/jama.2019.9052
[22] Treister-Goltzman Y, Yarza S, Peleg R.  Lipid profile in mild subclinical hypothyroidism: systematic review and meta-analysis[J]. Minerva Endocrinol (Torino), 2021, 46(4): 428-440.   doi: 10.23736/S2724-6507.20.03197-1
[23] Dahl AR, Iqbal AM, Lteif AN, et al.  Mild subclinical hypothyroidism is associated with paediatric dyslipidaemia[J]. Clin Endocrinol (Oxf), 2018, 89(3): 330-335.   doi: 10.1111/cen.13752
[24] Janovsky CCPS, Generoso G, Goulart AC, et al.  Differences in HDL particle size in the presence of subclinical thyroid dysfunctions: the ELSA-Brasil study[J]. Atherosclerosis, 2020, 312: 60-65.   doi: 10.1016/j.atherosclerosis.2020.08.021
[25] 陈春梅, 刘佳, 贾育梅, 等.  甲状腺功能正常人群血清促甲状腺激素水平与血脂的相关性[J]. 中国心血管杂志, 2020, 25(1): 45-49.   doi: 10.3969/j.issn.1007-5410.2020.01.011
Chen CM, Liu J, Jia YM, et al.  Correlation between serum thyroid-stimulating hormone and blood lipid in subjects with normal thyroid function[J]. Chin J Cardiovasc Med, 2020, 25(1): 45-49.   doi: 10.3969/j.issn.1007-5410.2020.01.011
[26] Liu LX, Liu J F, Fu SB, et al.  Correlation between serum TSH levels within normal range and serum lipid profile[J]. Horm Metab Res, 2021, 53(1): 32-40.   doi: 10.1055/a-1191-7953
[27] Grundy SM, Stone NJ, Bailey AL, et al.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines[J]. J Am Coll Cardiol, 2019, 73(24): e285-e350.   doi: 10.1016/j.jacc.2018.11.003
[28] Kotwal A, Cortes T, Genere N, et al.  Treatment of thyroid dysfunction and serum lipids: a systematic review and meta-analysis[J]. J Clin Endocrinol Metab, 2020, 105(12): 3683-3694.   doi: 10.1210/clinem/dgaa672
[29] McAninch EA, Rajan KB, Miller CH, et al.  Systemic thyroid hormone status during levothyroxine therapy in hypothyroidism: a systematic review and meta-analysis[J]. J Clin Endocrinol Metab, 2018, 103(12): 4533-4542.   doi: 10.1210/jc.2018-01361
[30]

Lee YK, Lee H, Han S, et al. Association between thyroid-stimulating hormone level after total thyroidectomy and hypercholesterolemia in female patients with differentiated thyroid cancer: a retrospective study[J/OL]. J Clin Med, 2019, 8(8): 1106[2022-04-01]. https://www.mdpi.com/2077-0383/8/8/1106. DOI: 10.3390/jcm8081106.
[31] 中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等.  血脂异常基层诊疗指南(2019年)[J]. 中华全科医师杂志, 2019, 18(5): 406-416.   doi: 10.3760/cma.j.issn.1671-7368.2019.05.003
Chinese Medical Association, Chinese Medical Journals Publishing House, Chinese Society of General Practice, et al.  Guideline for primary care of dyslipidemias (2019)[J]. Chin J Gen Pract, 2019, 18(5): 406-416.   doi: 10.3760/cma.j.issn.1671-7368.2019.05.003
[32]

Wang YP, Li QH, Yuan ZS, et al. Statin use and benefits of thyroid function: a retrospective cohort study[J/OL]. Front Endocrinol (Lausanne), 2021, 12: 578909[2022-04-01]. https://www.frontiersin.org/articles/10.3389/fendo.2021.578909/full. DOI: 10.3389/fendo.2021.578909.
[33] Krysiak R, Szkróbka W, Okopień B.  Atorvastatin potentiates the effect of selenomethionine on thyroid autoimmunity in euthyroid women with Hashimoto's thyroiditis[J]. Curr Med Res Opin, 2019, 35(4): 675-681.   doi: 10.1080/03007995.2018.1541314